» Articles » PMID: 20981144

Activation of PPARs α, β/δ, and γ Impairs TGF-β1-Induced Collagens' Production and Modulates the TIMP-1/MMPs Balance in Three-Dimensional Cultured Chondrocytes

Overview
Journal PPAR Res
Publisher Wiley
Date 2010 Oct 29
PMID 20981144
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background and Purpose. We investigated the potency of Peroxisome Proliferators-Activated Receptors (PPARs) α, β/δ, and γ agonists to modulate Transforming Growth Factor-β1 (TGF-β1-) induced collagen production or changes in Tissue Inhibitor of Matrix Metalloproteinase- (TIMP-) 1/Matrix Metalloproteinase (MMP) balance in rat chondrocytes embedded in alginate beads. Experimental Approach. Collagen production was evaluated by quantitative Sirius red staining, while TIMP-1 protein levels and global MMP (-1, -2, -3, -7, and -9) or specific MMP-13 activities were measured by ELISA and fluorigenic assays in culture media, respectively. Levels of mRNA for type II collagen, TIMP-1, and MMP-3 & 13 were quantified by real-time PCR. Key Results. TGF-β1 increased collagen deposition and type II collagen mRNA levels, while inducing TIMP-1 mRNA and protein expression. In contrast, it decreased global MMP or specific MMP-13 activities, while decreasing MMP-3 or MMP-13 mRNA levels. PPAR agonists reduced most of the effects of TGF-β1 on changes in collagen metabolism and TIMP-1/MMP balance in rat in a PPAR-dependent manner, excepted for Wy14643 on MMP activities. Conclusions and Implications. PPAR agonists reduce TGF-β1-modulated ECM turnover and inhibit chondrocyte activities crucial for collagen biosynthesis, and display a different inhibitory profile depending on selectivity for PPAR isotypes.

Citing Articles

Inhibition of miR-96-5p alleviates intervertebral disc degeneration by regulating the peroxisome proliferator-activated receptor γ/nuclear factor-kappaB pathway.

Li X, Hou Q, Yuan W, Zhan X, Yuan H J Orthop Surg Res. 2023; 18(1):916.

PMID: 38041147 PMC: 10691123. DOI: 10.1186/s13018-023-04412-1.


Impaired autophagy contributes to the aggravated deterioration of osteoarthritis articular cartilage by peroxisome proliferator-activated receptor α deficiency, associated with decreased ERK and Akt activation.

Zhou Y, Li L, Chen X, Zhao Q, Qu N, Zhang B Eur J Med Res. 2023; 28(1):332.

PMID: 37689723 PMC: 10492277. DOI: 10.1186/s40001-023-01267-4.


Peroxisome Proliferator-Activated Receptor Activation in Precision-Cut Bovine Liver Slices Reveals Novel Putative PPAR Targets in Periparturient Dairy Cows.

Busato S, Ford H, Abdelatty A, Estill C, Bionaz M Front Vet Sci. 2022; 9:931264.

PMID: 35903133 PMC: 9315222. DOI: 10.3389/fvets.2022.931264.


Identification of Transcription Factors Responsible for a Transforming Growth Factor-β-Driven Hypertrophy-like Phenotype in Human Osteoarthritic Chondrocytes.

Thielen N, Neefjes M, Vitters E, van Beuningen H, Blom A, Koenders M Cells. 2022; 11(7).

PMID: 35406794 PMC: 8998018. DOI: 10.3390/cells11071232.


The role of KDR in intrauterine adhesions may involve the TGF-β1/Smads signaling pathway.

Chen J, Yi X, Gu P, Gao S Braz J Med Biol Res. 2019; 52(10):e8324.

PMID: 31596310 PMC: 6787948. DOI: 10.1590/1414-431X20198324.


References
1.
Goldring M . The role of the chondrocyte in osteoarthritis. Arthritis Rheum. 2000; 43(9):1916-26. DOI: 10.1002/1529-0131(200009)43:9<1916::AID-ANR2>3.0.CO;2-I. View

2.
Goldring M . The role of cytokines as inflammatory mediators in osteoarthritis: lessons from animal models. Connect Tissue Res. 2000; 40(1):1-11. DOI: 10.3109/03008209909005273. View

3.
Desvergne B, Wahli W . Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev. 1999; 20(5):649-88. DOI: 10.1210/edrv.20.5.0380. View

4.
Kostadinova R, Wahli W, Michalik L . PPARs in diseases: control mechanisms of inflammation. Curr Med Chem. 2005; 12(25):2995-3009. DOI: 10.2174/092986705774462905. View

5.
Semple R, Chatterjee V, ORahilly S . PPAR gamma and human metabolic disease. J Clin Invest. 2006; 116(3):581-9. PMC: 1386124. DOI: 10.1172/JCI28003. View